Given the large stake in the stock by institutions, Qiagen's stock price might be vulnerable to their trading decisions 51% of the business is held by the top 18 shareholders Using data from analyst ...
VENLO, The Netherlands & REDWOOD CITY, Calif., February 13, 2025--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today ...
VENLO, The Netherlands & REDWOOD CITY, Calif. - QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA), a global provider of ...
Hosted on MSN15d
Is QIAGEN Stock an Apt Pick for Your Portfolio Right Now?QIAGEN N.V.’s QGEN long-term business strategy focuses on forming partnerships for the development, commercialization, marketing and distribution of existing and future products. The company sees ...
Qiagen (NYSE:QGEN – Get Free Report) is expected to post its quarterly earnings results after the market closes on Wednesday, ...
In a report released on February 6, Casey Woodring from J.P. Morgan maintained a Buy rating on Qiagen (QGEN – Research Report), with a price ...
Stock analysts at William Blair reduced their Q1 2025 earnings estimates for Qiagen in a research note issued on Friday, February 7th. William Blair analyst A. Brackmann now expects that the company ...
Kepler Capital analyst Maja Pataki maintained a Hold rating on Qiagen (QGEN – Research Report) on February 6 and set a price target of €42.17.
Qiagen QGEN reported its Q4 earnings results on Wednesday, February 5, 2025 at 04:05 PM. Here's what investors need to know ...
The diagnostic products maker posted revenue of $521.2 million in the period, beating Street forecasts. Seven analysts surveyed by Zacks expected $520.7 million. Qiagen expects full-year earnings to ...
QIAGEN N.V.’s QGEN long-term business strategy focuses on forming partnerships for the development, commercialization, marketing and distribution of existing and future products. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback